Skip to main content

Table 3 Full hepatic and metabolic profile among group A versus group B

From: Association between non-alcoholic fatty liver disease and epicardial adipose tissue volume with cardiometabolic risk in coronary heart disease

  Groups T test
Group A Group B t P value
ALT
Range 11–67 11–27 2.868 0.006*
Mean ± SD 26.295 ± 12.676 16.875 ± 5.377
AST
Range 12–67 11–25 3.498 0.001*
Mean ± SD 26.773 ± 11.620 16.250 ± 4.837
Alkaline phosphatase
Range 45–134 35–65 4.264  < 0.001*
Mean ± SD 68.114 ± 17.276 48.375 ± 10.794
Gamma GT
Range 2–54 4–12 6.389  < 0.001*
Mean ± SD 28.250 ± 12.920 7.375 ± 2.419
Fasting sugar
Range 80–400 100–250 0.722 0.473
Mean ± SD 199.455 ± 81.494 183.750 ± 49.244
HbA1C
Range 5–7.5 4.9–7.1  − 0.163 0.871
Mean ± SD 6.277 ± 0.743 6.313 ± 0.737
T. cholesterol
Range 101–225 130–190 0.112 0.911
Mean ± SD 157.227 ± 27.606 156.375 ± 21.229
LDL
Range 45–147 90–105  − 1.547 0.127
Mean ± SD 87.182 ± 23.695 96.500 ± 6.022
HDL
Range 25–62 43–50  − 1.626 0.109
Mean ± SD 42.227 ± 10.046 46.375 ± 2.419
TG
Range 65–347 130–200  − 2.887 0.005*
Mean ± SD 132.636 ± 44.186 166.250 ± 23.488
FIB-4
Range 0.39–2.98 0.41–1.5 1.729 0.089
Mean ± SD 1.100 ± 0.529 0.850 ± 0.386
NAFLD fibrosis scoring system
Range  − 4.46–1.34  − 3.73–0.06 1.039 0.303
Mean ± SD  − 1.250 ± 1.290  − 1.665 ± 1.568
  1. *mean significant